RECENT NEWS

Thermo Fisher Scientific has announced the commercial launch of its new EXENT Solution, after receiving IVDR certification. The EXENT solution is a fully integrated and automated mass spectrometry system designed to transform diagnosis and assessment for patients with monoclonal gammopathies, including multiple myeloma.

Diagnostics provider SYNLAB has set out its ambition to become the UK’s leading laboratory diagnostics organisation by 2027. It has unveiled a new vision, purpose and values which set a clear direction for the continued growth and success of each of its services in the UK – The Christie Pathology Partnership, Pathology First, Southwest Pathology Services, Synnovis, Lextox and SYNLAB Laboratory Services.

The Royal College of Pathologists (RCPath), the Institute of Biomedical Science (IBMS) and British Association for Cytopathology (BAC) have released a joint statement to guide the delivery of diagnostic cytopathology services across England.

The Royal College of Pathologists (RCPath) and the IBMS are jointly hosting the 2023 RCPath/IBMS Northern Symposium: Pathology and People. Taking place on 18 October at Cloth Hall Court, Leeds; the event will offer an exciting opportunity to meet, share experiences and network with local colleagues working in pathology in the North of England.

Virostat, which provides infectious disease antibody tools to researchers and manufacturers, has launched new monoclonal antibodies to avian influenza viruses, following reports from the Centers for Disease Control and Prevention (CDC) that the H5N1 bird influenza has been detected in several species of wild birds as well as domestic poultry flocks.

Thousands of people referred for urgent cancer checks every month are set to be diagnosed and treated sooner, as the NHS reforms its cancer standards to reflect what matters most to patients and to align with modern clinical practice.

Visiopharm and Boston Cell Standards have announced a partnership to develop a joint technology solution that enables laboratories to meet key provisions of regulatory changes proposed in a recent groundbreaking editorial.

An automated microscope combined with AI software can identify malaria parasites in blood samples almost as accurately as experts staffing microscopes used in standard diagnostic procedures, according to research carried out at University College London Hospitals (UCLH).

NHS organisations are being invited to take part in wireless trials to explore how cutting-edge technologies can help improve patient care. NHS England is supporting the trials to ensure health and care organisations make the most out of current and emerging wireless technology to deliver digital healthcare services.

Ohio State University Wexner Medical Center (OSWMC) is launching a multi-arm clinical utility and health economics study to measure the accuracy, efficiency and cost-savings impact of using AI tools in diagnosing cancer in a community hospital setting. The research will utilise Paige Prostate Detect, the only FDA-approved AI in pathology for detecting prostate cancer.

New research supported by the Medicines and Healthcare products Regulatory Agency (MHRA) has shown that the time to detect polio can be halved using a technique called Direct molecular Detection and Nanopore Sequencing (DDNS), supporting the global effort to eradicate polio and help save lives.

EMED Group, one of the largest healthcare logistic providers to the NHS, and Skyports Drone Services have successfully completed a proof-of-concept project for East Suffolk and North Essex NHS Foundation Trust aimed at bringing additional innovation and sustainability benefits to medical courier services.

HORIBA UK is to host a free-to-attend CPD webinar focusing on how a One Health multidisciplinary approach can enable beneficial changes in veterinary diagnostics and therapeutics usage.

Tecan has unveiled its Phase Separator, an innovative liquid-separation technology that promises to save time and improve accuracy in laboratory workflows. With specific applications in liquid biopsy and biobanking, its benefits will be felt in genomics, proteomics and across multiple disease areas, from oncology and neurodegenerative disease to metabolic disorders.

The number of people receiving lifesaving checks for cancer in the last year has hit nearly three million (2.92m) – more than any other year on record, the NHS says.

The College of American Pathologists (CAP) is updating the 2017 evidence-based practice guideline, ‘Human Papillomavirus (HPV) Testing in Head and Neck Carcinomas,’ which is available in draft form for public comment until 1 September, 2023.

StageBio, a provider of histopathology, image analysis, specimen archiving and biorepository services, has announced a new strategic partnership with Pathcore, a digital and computational pathology solutions provider. This collaboration aims to advance pathology solutions, offering enhanced digital workflows, and improved efficiency for clients worldwide.

Lab Innovations has announced its keynote speakers for this year, with Maggie Philbin OBE and Amazon jungle scientist Rosa Vásquez Espinoza headlining the Royal Society of Chemistry Theatre at the event.

The UK Health Security Agency (UKHSA) has launched its three-year strategy to combat both new and re-emerging threats and to protect health security. The new document sets out UKHSA’s vision and goals for the next three years to prepare for and respond to health threats and build the capabilities and technologies to protect the country in the future.

Global Access Diagnostics (GADx), a social enterprise prioritising equitable access to diagnostics, has relaunched IT-Leish, a rapid diagnostic test (RDT) for visceral leishmaniasis (VL).